Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a mechanistic review summarizing preclinical evidence linking TMEM97/sigma-2 receptor to endocrine resistance pathways; the source explicitly states evidence remains preclinical and further investigation is needed.
A narrative review article surveying established and emerging PSMA radiotheranostic approaches, synthesizing clinical trial evidence and recent developments for professional education rather than reporting original research findings.